Literature DB >> 23500467

Silencing of mitochondrial NADP(+)-dependent isocitrate dehydrogenase gene enhances glioma radiosensitivity.

Sung Youl Kim1, Young Hyun Yoo, Jeen-Woo Park.   

Abstract

Reactive oxygen species (ROS) levels are elevated in organisms that have been exposed to ionizing radiation and are protagonists in the induction of cell death. Recently, we demonstrated that the control of mitochondrial redox balance and the cellular defense against oxidative damage are primary functions of mitochondrial NADP(+)-dependent isocitrate dehydrogenase (IDPm) via the supply of NADPH for antioxidant systems. In the present study, we report an autophagic response to ionizing radiation in A172 glioma cells transfected with small interfering RNA (siRNA) targeting the IDPm gene. Autophagy in A172 transfectant cells was associated with enhanced autophagolysosome formation and GFP-LC3 punctuation/aggregation. Furthermore, we found that the inhibition of autophagy by chloroquine augmented apoptotic cell death of irradiated A172 cells transfected with IDPm siRNA. Taken together, our data suggest that autophagy functions as a survival mechanism in A172 cells against ionizing radiation-induced apoptosis and the sensitizing effect of IDPm siRNA and autophagy inhibitor on the ionizing radiation-induced apoptotic cell death of glioma cells offers a novel redox-active therapeutic strategy for the treatment of cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500467     DOI: 10.1016/j.bbrc.2013.02.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection.

Authors:  Julie A Reisz; Nidhi Bansal; Jiang Qian; Weiling Zhao; Cristina M Furdui
Journal:  Antioxid Redox Signal       Date:  2014-02-21       Impact factor: 8.401

2.  Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis.

Authors:  Daniel R Wahl; Joseph Dresser; Kari Wilder-Romans; Joshua D Parsels; Shuang G Zhao; Mary Davis; Lili Zhao; Maureen Kachman; Stefanie Wernisch; Charles F Burant; Meredith A Morgan; Felix Y Feng; Corey Speers; Costas A Lyssiotis; Theodore S Lawrence
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

3.  FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.

Authors:  Angelika Bilger; Martin-Immanuel Bittner; Anca-L Grosu; Nicole Wiedenmann; Philipp T Meyer; Elke Firat; Gabriele Niedermann; Wolfgang A Weber; Dušan Milanović
Journal:  Strahlenther Onkol       Date:  2014-06-14       Impact factor: 3.621

Review 4.  IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders.

Authors:  Ya Qi Gong; Shuang Wei; Yuan Yun Wei; Yong Lin Chen; Jian Cui; Yue Qiu Yu; Xiang Lin; Hong Xia Yan; Hui Qin; Lan Yi
Journal:  Oncol Lett       Date:  2022-06-24       Impact factor: 3.111

Review 5.  Wild-type and mutated IDH1/2 enzymes and therapy responses.

Authors:  Remco J Molenaar; Jaroslaw P Maciejewski; Johanna W Wilmink; Cornelis J F van Noorden
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 8.756

6.  Carbon ion radiation inhibits glioma and endothelial cell migration induced by secreted VEGF.

Authors:  Yang Liu; Yuanyuan Liu; Chao Sun; Lu Gan; Luwei Zhang; Aihong Mao; Yuting Du; Rong Zhou; Hong Zhang
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

7.  D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH.

Authors:  K Oizel; C Gratas; A Nadaradjane; L Oliver; F M Vallette; C Pecqueur
Journal:  Cell Death Dis       Date:  2015-03-26       Impact factor: 9.685

Review 8.  Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.

Authors:  Michael I Koukourakis; Achilleas G Mitrakas; Alexandra Giatromanolaki
Journal:  Br J Cancer       Date:  2016-02-18       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.